World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Dr Ulrike Lorch, MD FRCA FFPM
Medical Director

Dr Ulrike Lorch is a Co-Founder and Medical Director of Richmond Pharmacology. She holds Specialist Accreditation in Pharmaceutical Medicine and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians (UK) and a Fellow of the Royal College of Anaesthetists (UK). Dr Lorch is Educational Supervisor for physicians participating in Pharmaceutical Medicine Specialist Training. She is a member of the Education Committee and a member of the Board of Examiners of the Faculty of Pharmaceutical Medicine.

Dr Lorch has more than 10 years experience in conducting Early Phase clinical research. She has been Principal Investigator in more than 120 studies at Richmond Pharmacology and Co-Investigator in more than 100 further studies. She has special expertise in adaptive study designs in early phase clinical trials, First-into-Human and other exploratory studies in healthy volunteers and patients of all ages, ethnic comparison, cardiac safety (including TQT), pain and gastrointestinal pH monitoring studies.

Jointly with her colleagues at Richmond Pharmacology she was instrumental in obtaining Standard and Supplementary MHRA Phase I Accreditation for the two Richmond Pharmacology research units. As one of the Principal Investigators at Richmond Pharmacology she is accredited to conduct all types of Phase I studies, including those that -due to potential risks- require review by the Expert Advisory Group in addition to the standard review by the MHRA.

Dr Lorch is a member of the British Association of Pharmaceutical Physicians (BrAPP), a Committee member of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI, UK), the Phase I Advisory Group (National Research Ethics Service, Health Research Authority, UK), the Japanese Society of Pharmacology and Therapeutics and the Arbeitsgemeinschaft fur Angewandte Humanpharmakologie (AGAH, Germany).

The Royal College of Physicians and the Faculty of Pharmaceutical Medicine have published Dr Lorch's career profile on their websites. Two Fellows of the Faculty describe what they love about working in Pharmaceutical Medicine, how it differs from clinical medicine and what the challenges and benefits are of a career in the specialty. Please click here to view Dr Lorch's career profile.

Back to experts
r-gater-gater-gate

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more

Dr Jorg Taubel, CEO of Richmond Pharmacology, features on the PM Live website, discussing clincial trials and COVID-19

August 11, 2020
Dr Jorg Taubel discusses some of the steps taken at Richmond Pharmacology to ensure clinical trials can continue to operate at a high standard throughout the COVID-19 pandemic.
Read more